Ratings
0
Nobody has rated this yet. Be the first!
Works
5
The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
Targeted therapy: ready for prime time?
Author Reply: Decision-Making Management of Women with a High Risk of Developing Breast and Ovarian Cancer
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
